IMMUNOVANT, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
IMMUNOVANT, INC. (IMVT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 1.04 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- IMMUNOVANT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 1.04M shares, a 78.60% increase year-over-year.
- IMMUNOVANT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 174.74K shares, a 73.74% increase year-over-year.
- IMMUNOVANT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 236.56K shares, a 41.02% decline year-over-year.
- IMMUNOVANT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 210.19K shares, a 53.02% decline year-over-year.
- IMMUNOVANT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2026 was 1.21M shares, a 17.81% increase from fiscal 2025.
- IMMUNOVANT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 1.02M shares, a 305.94% increase from fiscal 2024.
- IMMUNOVANT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 252.28K shares, a 35.82% decline from fiscal 2023.
- IMMUNOVANT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 393.10K shares, a 84.83% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.04M shares 10-Q · filed 2026-08-06 | 1.22M shares derived: sum of 2 quarters · filed 2026-08-06 | 1.46M shares derived: sum of 3 quarters · filed 2026-08-06 | 1.67M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 174.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | 411.30K shares derived: sum of 2 quarters · filed 2026-05-20 | 621.49K shares derived: sum of 3 quarters · filed 2026-05-20 | 1.21M shares 10-K · filed 2026-05-20 |
| 2025-12-31 | 236.56K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | 446.75K shares derived: sum of 2 quarters · filed 2026-02-06 | 1.03M shares 10-Q · filed 2026-02-06 | 1.13M shares derived: sum of 4 quarters · filed 2026-02-06 |
| 2025-09-30 | 210.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | 795.17K shares 10-Q · filed 2025-11-10 | 895.75K shares derived: sum of 3 quarters · filed 2025-11-10 | 1.30M shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | 584.98K shares 10-Q · filed 2025-08-11 | 685.56K shares derived: sum of 2 quarters · filed 2025-08-11 | 1.09M shares derived: sum of 3 quarters · filed 2025-08-11 | 1.53M shares derived: sum of 4 quarters · filed 2025-08-11 |
| 2025-03-31 | 100.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | 501.63K shares derived: sum of 2 quarters · filed 2025-05-29 | 949.04K shares derived: sum of 3 quarters · filed 2025-05-29 | 1.02M shares 10-K · filed 2025-05-29 |
| 2024-12-31 | 401.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | 848.47K shares derived: sum of 2 quarters · filed 2025-02-06 | 923.53K shares 10-Q · filed 2025-02-06 | 1.10M shares derived: sum of 4 quarters · filed 2025-02-06 |
| 2024-09-30 | 447.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | 522.47K shares 10-Q · filed 2024-11-07 | 697.05K shares derived: sum of 3 quarters · filed 2024-11-07 | 728.32K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 75.06K shares 10-Q · filed 2024-08-06 | 249.63K shares derived: sum of 2 quarters · filed 2024-08-06 | 280.90K shares derived: sum of 3 quarters · filed 2024-08-06 | 319.39K shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 174.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | 205.85K shares derived: sum of 2 quarters · filed 2024-05-29 | 244.34K shares derived: sum of 3 quarters · filed 2024-05-29 | 252.28K shares 10-K · filed 2024-05-29 |
| 2023-12-31 | 31.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | 69.76K shares derived: sum of 2 quarters · filed 2024-02-12 | 77.70K shares 10-Q · filed 2024-02-12 | 195.76K shares derived: sum of 4 quarters · filed 2024-02-12 |
| 2023-09-30 | 38.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | 46.43K shares 10-Q · filed 2023-11-09 | 164.50K shares derived: sum of 3 quarters · filed 2023-11-09 | 267.66K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 7.94K shares 10-Q · filed 2023-08-10 | 126.01K shares derived: sum of 2 quarters · filed 2023-08-10 | 229.17K shares derived: sum of 3 quarters · filed 2023-08-10 | 306.07K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 118.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-22 | 221.23K shares derived: sum of 2 quarters · filed 2023-05-22 | 298.13K shares derived: sum of 3 quarters · filed 2023-05-22 | 393.10K shares 10-K · filed 2023-05-22 |
| 2022-12-31 | 103.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-03 | 180.07K shares derived: sum of 2 quarters · filed 2023-02-03 | 275.04K shares 10-Q · filed 2023-02-03 | 356.06K shares derived: sum of 4 quarters · filed 2023-02-03 |
| 2022-09-30 | 76.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-04 | 171.87K shares 10-Q · filed 2022-11-04 | 252.89K shares derived: sum of 3 quarters · filed 2022-11-04 | 291.24K shares derived: sum of 4 quarters · filed 2022-11-04 |
| 2022-06-30 | 94.97K shares 10-Q · filed 2022-08-05 | 175.99K shares derived: sum of 2 quarters · filed 2022-08-05 | 214.34K shares derived: sum of 3 quarters · filed 2022-08-05 | 977.29K shares derived: sum of 4 quarters · filed 2022-08-05 |
| 2022-03-31 | 81.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-08 | 119.37K shares derived: sum of 2 quarters · filed 2022-06-08 | 882.32K shares derived: sum of 3 quarters · filed 2022-06-08 | 2.59M shares 10-K · filed 2022-06-08 |
| 2021-12-31 | 38.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-04 | 801.30K shares derived: sum of 2 quarters · filed 2022-02-04 | 2.51M shares 10-Q · filed 2022-02-04 | 2.52M shares derived: sum of 4 quarters · filed 2022-02-04 |
| 2021-09-30 | 762.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-05 | 2.47M shares 10-Q · filed 2021-11-05 | 2.48M shares derived: sum of 3 quarters · filed 2021-11-05 | 2.79M shares derived: sum of 4 quarters · filed 2021-11-05 |
| 2021-06-30 | 1.71M shares 10-Q · filed 2021-08-09 | 1.72M shares derived: sum of 2 quarters · filed 2021-08-09 | 2.03M shares derived: sum of 3 quarters · filed 2021-08-09 | 2.08M shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 6.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-01 | 322.67K shares derived: sum of 2 quarters · filed 2021-06-01 | 372.67K shares derived: sum of 3 quarters · filed 2021-06-01 | 384.41K shares 10-K · filed 2021-06-01 |
| 2020-12-31 | 316.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | 366.37K shares derived: sum of 2 quarters · filed 2021-02-16 | 378.11K shares 10-Q · filed 2021-02-16 | 526.73K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2020-09-30 | 50.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | 61.74K shares 10-Q · filed 2020-11-12 | 210.36K shares derived: sum of 3 quarters · filed 2020-11-12 | |
| 2020-06-30 | 11.74K shares 10-Q · filed 2020-08-12 | 160.36K shares derived: sum of 2 quarters · filed 2020-08-12 | ||
| 2020-03-31 | 148.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | 719.05K shares 10-K · filed 2020-06-29 | ||
| 2019-12-31 | 570.43K shares 10-Q · filed 2020-02-14 | |||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 375.00K shares 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | 375.00K shares 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |